Cytosorbents Corporation
US ˙ NasdaqCM ˙ US23283X2062

Introduction

This page provides a comprehensive analysis of the known insider trading history of Chan Phillip P.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Chan Phillip P. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CTSO / Cytosorbents Corporation Chief Executive Officer, Director 1,382,963
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Chan Phillip P.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CTSO / Cytosorbents Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTSO / Cytosorbents Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2023-12-13 CTSO Chan Phillip P. 75,188 1.3300 75,188 1.3300 100,000 7 1.8400 38,346 38.35
2022-12-08 CTSO Chan Phillip P. 5,859 1.2600 5,859 1.2600 7,382
2022-12-07 CTSO Chan Phillip P. 9,850 1.2600 9,850 1.2600 12,411
2022-12-06 CTSO Chan Phillip P. 14,291 1.2640 14,291 1.2640 18,064
2022-09-08 CTSO Chan Phillip P. 35,000 1.7000 35,000 1.7000 59,500
2022-06-09 CTSO Chan Phillip P. 16,000 2.1740 16,000 2.1740 34,784
2021-12-10 CTSO Chan Phillip P. 5,000 5.2500 5,000 5.2500 26,250
2019-12-06 CTSO Chan Phillip P. 16,500 3.6000 16,500 3.6000 59,400
2017-06-08 CTSO Chan Phillip P. 3,700 4.0000 3,700 4.0000 14,800
2017-06-05 CTSO Chan Phillip P. 6,300 4.0000 6,300 4.0000 25,200
2016-12-09 CTSO Chan Phillip P. 4,600 5.4000 4,600 5.4000 24,840
2016-08-24 CTSO Chan Phillip P. 5,000 4.8900 5,000 4.8900 24,450
2012-09-04 CTSO Chan Phillip P. 190,000 0.1300 7,600 3.2500 24,700

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CTSO / Cytosorbents Corporation Insider Trades
Insider Sales CTSO / Cytosorbents Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CTSO / Cytosorbents Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2018-12-07 CTSO Chan Phillip P. 24,337 9.3695 24,337 9.3695 228,026 363 3.6100 -140,168 -61.47
2018-09-07 CTSO Chan Phillip P. 2,731 14.1100 2,731 14.1100 38,534
2018-09-06 CTSO Chan Phillip P. 2,900 14.7500 2,900 14.7500 42,775
2018-09-05 CTSO Chan Phillip P. 600 14.8500 600 14.8500 8,910
2018-09-05 CTSO Chan Phillip P. 5,187 14.8500 5,187 14.8500 77,027

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CTSO / Cytosorbents Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Chan Phillip P. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-08 2025-08-08 4 CTSO Cytosorbents Corp
Common Stock
A - Award 105,600 1,382,963 8.27
2025-02-26 2025-02-24 4 CTSO Cytosorbents Corp
Common Stock
O - Other 34,168 1,277,363 2.75 1.13 38,610 1,443,420
2025-01-22 2025-01-17 4 CTSO Cytosorbents Corp
Common Stock
X - Other 90,832 1,243,195 7.88 1.00 90,832 1,243,195
2024-04-04 2024-04-02 4 CTSO Cytosorbents Corp
Common Stock
A - Award 96,000 1,164,704 8.98
2023-12-15 2023-12-13 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 75,188 1,068,704 7.57 1.33 100,000 1,421,376
2023-07-11 2023-07-07 4 CTSO Cytosorbents Corp
Common Stock
A - Award 87,000 1,006,548 9.46
2023-04-05 2023-04-03 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 30,500 927,779 3.40 2.88 87,688 2,667,365
2022-12-09 2022-12-08 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 5,859 897,279 0.66 1.26 7,382 1,130,572
2022-12-08 2022-12-07 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 9,850 891,420 1.12 1.26 12,411 1,123,189
2022-12-08 2022-12-06 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 14,291 881,570 1.65 1.26 18,064 1,114,304
2022-09-12 2022-09-08 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 35,000 867,279 4.21 1.70 59,500 1,474,374
2022-08-12 2022-08-10 4 CTSO Cytosorbents Corp
Common Stock
A - Award 79,000 845,130 10.31
2022-06-21 2022-06-16 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase X 2,221 768,351 0.29 1.85 4,109 1,421,449
2022-06-10 2022-06-09 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 16,000 766,130 2.13 2.17 34,784 1,665,567
2022-01-03 2021-12-30 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase X 5,462 768,443 0.72 4.05 22,121 3,112,194
2022-01-03 2021-12-29 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase X 9,438 762,981 1.25 4.05 38,224 3,090,073
2022-01-03 2021-12-29 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase X 100 753,543 0.01 4.04 404 3,044,314
2021-12-13 2021-12-10 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 5,000 753,443 0.67 5.25 26,250 3,955,576
2021-04-14 2021-04-12 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 96,000 96,000
2021-04-14 2021-04-12 4 CTSO Cytosorbents Corp
Common Stock
A - Award 72,000 769,339 10.32 8.99 647,280 6,916,358
2020-05-07 2020-05-05 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
M - Exercise -14,100 0 -100.00
2020-05-07 2020-05-05 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 14,100 714,682 2.01 9.39 132,399 6,710,864
2020-03-03 2020-02-28 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 80,000 80,000
2020-03-03 2020-02-28 4 CTSO Cytosorbents Corp
Common Stock
A - Award 60,000 711,178 9.21
2019-12-06 2019-12-06 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 16,500 657,688 2.57 3.60 59,400 2,367,677
2019-08-19 2019-08-15 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
M - Exercise -75,000 14,100 -84.18
2019-08-19 2019-08-15 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 75,000 641,188 13.25 3.45 258,750 2,212,099
2019-07-24 2019-07-22 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 80,000 80,000
2019-07-24 2019-07-22 4 CTSO Cytosorbents Corp
Common Stock
A - Award 60,000 575,582 11.64
2019-06-11 2019-06-07 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
M - Exercise -20,000 0 -100.00
2019-06-11 2019-06-07 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 20,000 515,582 4.04 4.32 86,500 2,229,892
2019-03-29 2019-03-04 4/A CTSO Cytosorbents Corp
Common Stock
A - Award 5,500 496,383 1.12
2019-03-06 2019-03-04 4 CTSO Cytosorbents Corp
Common Stock
A - Award 5,500 431,149 1.29
2018-12-11 2018-12-07 4 CTSO Cytosorbents Corp
Non-Statutory Stock Option (right to buy)
M - Exercise 89,337 0 -100.00
2018-12-11 2018-12-07 4 CTSO Cytosorbents Corp
Common Stock
S - Sale -24,337 503,281 -4.61 9.37 -228,026 4,715,491
2018-12-11 2018-12-07 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 89,337 527,618 20.38 2.10 187,608 1,107,998
2018-09-07 2018-09-07 4 CTSO Cytosorbents Corp
Non-Statutory Stock Option (right to buy)
M - Exercise 2,731 89,337 3.15
2018-09-07 2018-09-07 4 CTSO Cytosorbents Corp
Common Stock
S - Sale -2,731 438,281 -0.62 14.11 -38,534 6,184,145
2018-09-07 2018-09-07 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 2,731 449,699 0.61 2.10 5,735 944,368
2018-09-07 2018-09-06 4 CTSO Cytosorbents Corp
Non-Statutory Stock Option (right to buy)
M - Exercise 2,900 92,068 3.25
2018-09-07 2018-09-06 4 CTSO Cytosorbents Corp
Common Stock
S - Sale -2,900 441,012 -0.65 14.75 -42,775 6,504,927
2018-09-07 2018-09-06 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 2,900 446,968 0.65 2.10 6,090 938,633
2018-09-07 2018-09-05 4 CTSO Cytosorbents Corp
Non-Statutory Stock Option (right to buy)
M - Exercise 5,187 94,968 5.78
2018-09-07 2018-09-05 4 CTSO Cytosorbents Corp
Non-Statutory Stock Option (right to buy)
M - Exercise 600 0 -100.00
2018-09-07 2018-09-05 4 CTSO Cytosorbents Corp
Common Stock
S - Sale -5,187 443,912 -1.15 14.85 -77,027 6,592,093
2018-09-07 2018-09-05 4 CTSO Cytosorbents Corp
Common Stock
S - Sale -600 449,099 -0.13 14.85 -8,910 6,669,120
2018-09-07 2018-09-05 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 5,187 444,068 1.18 2.10 10,893 932,543
2018-09-07 2018-09-05 4 CTSO Cytosorbents Corp
Common Stock
M - Exercise 600 438,881 0.14 2.00 1,200 877,762
2018-06-14 2018-06-11 4 CTSO Cytosorbents Corp
Common Stock Warrants (right to buy)
X - Other -8,000 0 -100.00
2018-06-14 2018-06-11 4 CTSO Cytosorbents Corp
Common Stock
X - Other 8,000 461,281 1.76 3.75 30,000 1,729,804
2018-03-19 2018-03-15 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 117,750 117,750
2018-03-19 2018-03-15 4 CTSO Cytosorbents Corp
Common Stock
A - Award 10,300 440,713 2.39
2018-03-02 2018-02-28 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 95,200 95,200
2018-03-02 2018-02-28 4 CTSO Cytosorbents Corp
Common Stock
A - Award 43,000 430,413 11.10
2017-06-08 2017-06-08 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 3,700 399,907 0.93 4.00 14,800 1,599,628
2017-06-06 2017-06-05 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 6,300 396,207 1.62 4.00 25,200 1,584,828
2017-02-28 2017-02-24 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 112,000 112,000
2017-02-28 2017-02-24 4 CTSO Cytosorbents Corp
Common Stock
A - Award 18,700 389,907 5.04
2017-02-28 2017-02-24 4 CTSO Cytosorbents Corp
Common Stock
A - Award 40,625 184,207 28.29
2017-02-01 2017-01-30 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 77,600 77,600
2016-12-13 2016-12-09 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 4,600 448,103 1.04 5.40 24,840 2,419,756
2016-08-26 2016-08-24 4 CTSO Cytosorbents Corp
Common Stock
P - Purchase 5,000 121,648 4.29 4.89 24,450 594,859
2016-06-09 2016-06-07 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 97,000 97,000
2016-06-09 2016-06-07 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 7,000 7,000
2016-06-09 2016-06-07 4 CTSO Cytosorbents Corp
Common Stock
A - Award 57,000 190,982 42.54
2016-06-09 2016-06-07 4 CTSO Cytosorbents Corp
Common Stock
A - Award 26,000 133,982 24.08
2016-05-06 2016-05-04 4 CTSO Cytosorbents Corp
Common Stock
J - Other 19,757 107,982 22.39
2016-05-06 2015-12-30 4 CTSO Cytosorbents Corp
Common Stock
J - Other 2,903 88,225 3.40
2016-05-06 2015-09-09 4 CTSO Cytosorbents Corp
Common Stock
J - Other 9,879 85,322 13.09
2015-10-21 2015-10-19 4 CTSO Cytosorbents Corp
Warrant (right to buy)
X - Other -2,000 0 -100.00
2015-10-21 2015-10-19 4 CTSO Cytosorbents Corp
Warrant (right to buy)
X - Other -800 0 -100.00
2015-10-21 2015-10-19 4 CTSO Cytosorbents Corp
Warrant (right to buy)
X - Other -667 0 -100.00
2015-10-21 2015-10-19 4 CTSO Cytosorbents Corp
Common Stock
X - Other 2,000 75,443 2.72 2.50 5,000 188,608
2015-10-21 2015-10-19 4 CTSO Cytosorbents Corp
Common Stock
X - Other 800 73,442 1.10 3.12 2,500 229,506
2015-10-21 2015-10-19 4 CTSO Cytosorbents Corp
Common Stock
X - Other 667 72,643 0.93 3.75 2,501 272,411
2015-04-10 2015-04-08 4 CTSO Cytosorbents Corp
Stock Option (right to buy)
A - Award 70,000 70,000
2015-04-10 2015-04-08 4 CTSO Cytosorbents Corp
Common Stock
A - Award 130,000 130,000
2014-10-29 2014-10-09 4 CTSO Cytosorbents Corp
Series B 10% Convertible Preferred Stock
C - Conversion -384 0 -100.00
2014-10-29 2014-10-09 4 CTSO Cytosorbents Corp
Common Stock
C - Conversion 1,061,354 1,799,376 143.81
2014-07-24 2014-03-28 4 CTSO Cytosorbents Corp
Stock Option
A - Award 1,750,000 1,750,000
2013-07-17 2013-06-21 4 CTSO Cytosorbents Corp
Warrants
P - Purchase 1 1
2013-07-17 2013-06-21 4 CTSO Cytosorbents Corp
Convertible Note
P - Purchase 50,000.00
2013-07-17 2013-04-04 4 CTSO Cytosorbents Corp
Stock Option
A - Award 1,650,000 8,113,042 25.53
2013-02-14 2009-10-05 5 CTSO Cytosorbents Corp
Series B Convertible Preferred
C - Conversion 100 294 51.59 10,000.00 1,000,000 2,938,400
2012-09-05 2012-09-04 4 CTSO Cytosorbents Corp
Common Stock, par value $0.001 per share
P - Purchase 190,000 190,000 0.13 24,700 24,700
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)